SELF-REPORTED MULTI-MORBIDITY WITH TUBERCULOSIS: DATA FROM THE KHYBER PAKHTUNKHWA INTEGRATED POPULATION HEALTH SURVEY (KPIPHS) IN PAKISTAN.

Publication date: Nov 29, 2024

With the rise of non-communicable diseases (NCDs) in a country that is already facing high tuberculosis (TB) burden, TB multi-morbidity is likely to pose a significant public health challenge in Pakistan. Data were analysed to determine the prevalence of TB and explore the distribution and determinants of multi-morbidity associated with TB in the population of Khyber Pakhtunkhwa -a province of Pakistan. This is a secondary analysis of data gathered as part of the KPIPHS survey conducted in 2016-17 in both the rural and urban areas of Khyber Pakhtunkhwa, Pakistan. An interviewer-administered questionnaire was used to collect data, from adults, on demographics, education and socioeconomic status, physical and mental health, reproductive health, child health, health-related quality of life, and self-reported cardiometabolic diseases including Diabetes, hypertension, renal disorders, cardiac failure, angina, and stroke. A total of 20,715 participants were recruited in the survey including 52. 8% (n=10,943) males and 47. 2% (n=9,772) females with a mean age of 41 (13. 1) years. Data on TB status was available for a total of 14452 participants. The prevalence of TB in Khyber Pakhtunkhwa was found to be 0. 49% (n=72) including an almost equal number of males and females [48% (n=34) vs 51% (n=36)], respectively. The mean age of the patients with TB was 47. 5 (11. 6) years. A higher proportion of people with TB had cardiometabolic diseases compared to people without TB (45. 9% vs. 30. 9%). Amongst the cardiometabolic disorders, self-reported hypertension (OR: 1. 81, 95% CI 1. 08-3. 02, p=0. 02), Diabetes (OR: 3. 99, 95% CI 1. 95-8. 18, p=

Concepts Keywords
Cardiometabolic Adult
Diabetes Diabetes Mellitus
Pakhtunkhwa Female
Socioeconomic Health Surveys
Humans
Male
Middle Aged
Multimorbidity
Pakistan
Prevalence
Self Report
Tuberculosis

Semantics

Type Source Name
disease MESH MORBIDITY
disease MESH TUBERCULOSIS
pathway KEGG Tuberculosis
disease MESH non-communicable diseases
disease IDO country
disease IDO quality
disease MESH hypertension renal
disease MESH cardiac failure
disease MESH stroke
drug DRUGBANK Aspartame
disease MESH hypertension
disease MESH comorbidity
disease MESH Diabetes Mellitus

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *